Literature DB >> 10051448

Intestinal trefoil factor binds to intestinal epithelial cells and induces nitric oxide production: priming and enhancing effects of mucin.

X D Tan1, Q P Liu, W Hsueh, Y H Chen, H Chang, F Gonzalez-Crussi.   

Abstract

Intestinal trefoil factor (ITF or TFF3), NO and epithelium-associated mucin have important roles in sustaining mucosal integrity in the gastrointestinal tract. In the present study we examined ITF-binding molecules on IEC-18 cells (an intestinal epithelial cell line) with the use of flow cytometry and localized these molecules on the cell surface by confocal microscopy. Furthermore, we studied the interaction of mucin and ITF and their co-operative effect on NO production by the epithelium. Stimulation of cells with mucin (5 mg/ml) for 90 min resulted in a 5-fold increase in ITF binding. Treatment of IEC-18 cells with actinomycin D or cycloheximide attenuated mucin-enhanced ITF binding. Ligand blot analysis confirmed the induction of ITF-binding protein in IEC-18 cells by mucin. These results indicate that transcriptional and translational mechanisms are involved in the effect of mucin. Treatment with ITF overnight resulted in a low level of nitrite production by the cells, a 5-fold increase over control, in a concentration-dependent manner. ITF-induced NO production was attenuated by 1400W, a selective type II nitric oxide synthase (NOS2) inhibitor. By immunoblotting we found that NOS2 was up-regulated by ITF treatment. Priming IEC-18 cells with mucin for 90 min enhanced the effect of ITF on NO production, suggesting that the up-regulation of ITF-binding molecules by mucin might be physiologically relevant. Taken together, these observations indicate (1) that ITF-binding molecules that are up-regulated by mucin exist on the intestinal epithelial surface, and (2) that ITF modulates epithelial NO production via the NOS2 pathway, which is enhanced by mucin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10051448      PMCID: PMC1220112     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

Review 1.  The trefoil peptide family.

Authors:  B E Sands; D K Podolsky
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

2.  NO chi generation by cultured small intestinal epithelial cells.

Authors:  A U Dignass; D K Podolsky; D Rachmilewitz
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

3.  Immunoprecipitation and characterization of a binding protein specific for the peptide, intestinal trefoil factor.

Authors:  R Chinery; H M Cox
Journal:  Peptides       Date:  1995       Impact factor: 3.750

4.  Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage.

Authors:  R J Playford; T Marchbank; R A Goodlad; R A Chinery; R Poulsom; A M Hanby
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells.

Authors:  J A Efstathiou; M Noda; A Rowan; C Dixon; R Chinery; A Jawhari; T Hattori; N A Wright; W F Bodmer; M Pignatelli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-17       Impact factor: 11.205

6.  Modulation of epidermal growth factor effects on epithelial ion transport by intestinal trefoil factor.

Authors:  R Chinery; H M Cox
Journal:  Br J Pharmacol       Date:  1995-05       Impact factor: 8.739

7.  Role of nitric oxide in restitution of injured guinea pig gastric mucosa in vitro.

Authors:  A Yanaka; H Muto; H Fukutomi; S Ito; W Silen
Journal:  Am J Physiol       Date:  1995-06

8.  Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor.

Authors:  H Mashimo; D C Wu; D K Podolsky; M C Fishman
Journal:  Science       Date:  1996-10-11       Impact factor: 47.728

9.  Nitric oxide is necessary for a switch from stationary to locomoting phenotype in epithelial cells.

Authors:  E Noiri; T Peresleni; N Srivastava; P Weber; W F Bahou; N Peunova; M S Goligorsky
Journal:  Am J Physiol       Date:  1996-03

Review 10.  Mucin gene structure and expression: protection vs. adhesion.

Authors:  B J Van Klinken; J Dekker; H A Büller; A W Einerhand
Journal:  Am J Physiol       Date:  1995-11
View more
  8 in total

1.  TFF3 modulates NF-{kappa}B and a novel negative regulatory molecule of NF-{kappa}B in intestinal epithelial cells via a mechanism distinct from TNF-{alpha}.

Authors:  Ya-Qin Zhu; Xiao-Di Tan
Journal:  Am J Physiol Cell Physiol       Date:  2005-07-13       Impact factor: 4.249

Review 2.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

3.  Selective reduction of intestinal trefoil factor in untreated coeliac disease.

Authors:  C Ciacci; D Di Vizio; R Seth; G Insabato; G Mazzacca; D K Podolsky; Y R Mahida
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

4.  Cyclooxygenase 2, pS2, inducible nitric oxide synthase and transforming growth factor alpha in gastric adaptation to stress.

Authors:  Shi-Nan Nie; Hai-Chen Sun; Xue-Hao Wu; Xiao-Ming Qian
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

5.  Effect of astragaloside IV on diabetic gastric mucosa in vivo and in vitro.

Authors:  Ningding Wang; Frederick Siu; Yongbin Zhang
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 6.  Trefoil factors in inflammatory bowel disease.

Authors:  Luise Aamann; Else Marie Vestergaard; Henning Grønbæk
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

7.  Cellular localization, binding sites, and pharmacologic effects of TFF3 in experimental colitis in mice.

Authors:  Stine Kjellev; Lars Thim; Charles Pyke; Steen S Poulsen
Journal:  Dig Dis Sci       Date:  2007-03-07       Impact factor: 3.199

8.  CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression.

Authors:  Hong-Yong Cui; Shi-Jie Wang; Fei Song; Xu Cheng; Gang Nan; Yu Zhao; Mei-Rui Qian; Xi Chen; Jia-Yue Li; Fen-Ling Liu; Yu-Meng Zhu; Ruo-Fei Tian; Bin Wang; Bin Wu; Yang Zhang; Xiu-Xuan Sun; Ting Guo; Xiang-Min Yang; Hai Zhang; Ling Li; Jing Xu; Hui-Jie Bian; Jian-Li Jiang; Zhi-Nan Chen
Journal:  Signal Transduct Target Ther       Date:  2021-07-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.